Astrana Health (Astrana Health) Debt-to-Equity : 0.52 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Astrana Health Debt-to-Equity?

Astrana Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $25 Mil. Astrana Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $296 Mil. Astrana Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $614 Mil. Astrana Health's debt to equity for the quarter that ended in Dec. 2023 was 0.52.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Astrana Health's Debt-to-Equity or its related term are showing as below:

ASTH' s Debt-to-Equity Range Over the Past 10 Years
Min: -27.94 Med: 0.25 Max: 1.34
Current: 0.52

During the past 13 years, the highest Debt-to-Equity Ratio of Astrana Health was 1.34. The lowest was -27.94. And the median was 0.25.

ASTH's Debt-to-Equity is ranked worse than
52.08% of 553 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs ASTH: 0.52

Astrana Health Debt-to-Equity Historical Data

The historical data trend for Astrana Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astrana Health Debt-to-Equity Chart

Astrana Health Annual Data

Trend

Jan14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.34

0.79

0.45

0.42

0.52

Astrana Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.42	0.41	0.41	0.40	0.52

Competitive Comparison of Astrana Health's Debt-to-Equity

For the Medical Care Facilities subindustry, Astrana Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astrana Health's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Astrana Health's Debt-to-Equity falls into.

Astrana Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Astrana Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(24.753	+	296.261)	/	614.218
	=	0.52

Astrana Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(24.753	+	296.261)	/	614.218
	=	0.52

Astrana Health (NAS:ASTH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Astrana Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Astrana Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Astrana Health (Astrana Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Astrana Health Inc (NAS:ASTH) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

3AM:Germany

Address

1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801

Website

https://www.apollomed.net

Apollo Medical Holdings Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care in a cost-effective manner. It is focused on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Executives

Chandan Basho	officer: See Remarks	1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
John Vong	officer: SVP-Chief Accounting Officer	4288 BIRCHWOOD AVENUE, SEAL BEACH CA 90740
Linda Marsh	director	100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801
Allied Physicians Of California, A Profession Medical Corp	10 percent owner	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Weili Dai,	director	1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
J. Lorraine Estradas	director	1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
David Schmidt	director	700 N. BRAND BLVD, SUITE 220, GLENDALE CA 91203
Albert Waichow Young	officer: Chief Administrative Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Adrian Vazquez	officer: Chief Medical Officer	C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Thomas S. Lam	director, officer: President and Co-CEO	1668 GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Kenneth T. Sim	director, officer: Executive Chairman and Co-CEO	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Brandon Sim	director, officer: See Remarks	C/O APOLLO MEDICAL HOLDINGS, INC., 1668 S. GARFIELD AVENUE, 3RD FLOOR, ALHAMBRA CA 91801
Eric Chin	officer: Chief Financial Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Michael F. Eng	director	712 BATAAN PLACE, MONTEREY PARK CA 91755
Hing Ang	officer: Chief Operating Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801